Skip to main content
Equibles

Nasrat Hussain

Analyst

UBS

Equibles does not estimate personal net worth.

About Nasrat Hussain

Nasrat Hussain is recorded as Analyst at UBS. Nasrat Hussain has spoken on 1 earnings call across 1 company, most recently for Zealand Pharma A/S on May 7, 2026. The companies whose calls Nasrat Hussain spoke on are classified in the Healthcare sector.

Nasrat Hussain on recent calls

“First, with Phase 3 MASSL data for server data coming at ADA and the ongoing Phase 3 MASS trials across F2, F3, and F4, could you outline the major differences between patients that you enrolled for MASSL and MASS trials?”
Analyst — UBS, Q1 Financial Results / Interim Report First Quarter 2026 ·

Affiliation history

  • UBS

    Analyst

    Transcript header (unverified)

    Current

Company network

Recent activity